Extract: Plasminogen-activator activity was measured in lungs from 7 newborn premature infants examined at autopsy (control lungs) and 11 infants dying of hyaline membrane disease (hyaline membrane ...
Credit: Getty Images. Ryplazim works by temporarily increasing plasminogen levels in blood. Ryplazim ® (plasminogen, human-tmvh) is currently being provided in a very limited supply, according to ...
Today, the U.S. Food and Drug Administration approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with plasminogen deficiency type 1, also referred to as hypoplasminogenemia, a ...
Ryplazim is supplied in a 50mL single-dose vial containing 68.8mg of plasminogen as a lyophilized powder for intravenous use after reconstitution. Kedrion Biopharma has resolved its supply issue for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results